Inactive Instrument

Press Releases Acura Pharmaceuticals, Inc. Other OTC

Equities

ACUR

US00509L8028

Press Releases

Unlock all the news: Be the first to know and act before the market!

Acura Pharmaceuticals : TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT - Form 8-K	03-26	PU
Acura Pharmaceuticals : AMENDED, CONSOLIDATED AND RESTATED SECURED PROMISSORY NOTE - Form 8-K	12-21	PU
Acura Pharmaceuticals : New Financial Obligation - Form 8-K	12-06	PU
Acura Pharmaceuticals : Termination of Material Agreement - Form 8-K	16/08/23	PU
Acura Pharmaceuticals : TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT - Form 8-K	28/06/23	PU
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	20/03/23	AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	22/02/23	AQ
ACURA PHARMACEUTICALS, INC : Other Events (form 8-K)	13/02/23	AQ
ACURA PHARMACEUTICALS, INC : Other Events (form 8-K)	02/02/23	AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	20/01/23	AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	27/12/22	AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	14/11/22	AQ
Acura Pharmaceuticals : NEGOTIABLE PROMISSORY NOTE - Form 8-K	17/10/22	PU
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	17/10/22	AQ
Acura Pharmaceuticals : NEGOTIABLE PROMISSORY NOTE - Form 8-K	26/09/22	PU
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	26/09/22	AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	26/08/22	AQ
ACURA PHARMACEUTICALS, INC : Other Events (form 8-K)	28/07/22	AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	19/07/22	AQ
ACURA PHARMACEUTICALS, INC : Other Events (form 8-K)	14/07/22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Acura Pharmaceuticals, Inc. Other OTC

Equities

ACUR

US00509L8028

Press Releases

Filters